Clover Health Investments (CLOV) Change in Account Payables (2020 - 2026)

Clover Health Investments' Change in Account Payables history runs 7 years deep, the most recent figure standing at -$65.3 million for Q1 2026.

• Quarterly Change in Account Payables fell 50.3% year-over-year to -$65.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$44.5 million (down 215.07% YoY) and the FY2025 annual result came in at -$22.6 million, down 17.96% from the prior year.
• Change in Account Payables was -$65.3 million for Q1 2026 at Clover Health Investments, down from -$18.3 million in the prior quarter.
• Across five years, Change in Account Payables topped out at $109.2 million in Q3 2022 and bottomed at -$94.8 million in Q4 2022.
• A 5-year average of -$5.5 million and a median of -$13.6 million in 2023 frame the typical range for Change in Account Payables.
• Peak annual rise in Change in Account Payables reached 1204.74% in 2022, while the deepest fall reached 1900.91% in 2022.
• Clover Health Investments' Change in Account Payables stood at -$94.8 million in 2022, then jumped by 93.22% to -$6.4 million in 2023, then slumped by 215.55% to -$20.3 million in 2024, then climbed by 9.78% to -$18.3 million in 2025, then tumbled by 256.95% to -$65.3 million in 2026.
• Business Quant data shows CLOV's Change in Account Payables at -$65.3 million in Q1 2026, -$18.3 million in Q4 2025, and $38.9 million in Q3 2025.